ArticleBiomedicines2023

Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders.

Diego Bagnasco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.